Lamar Ballweber-Fleming

9PUBLICATIONS
125CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsInnate immunityPainApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

K Rachael Parks, Zoe Moodie, Mary A Allen

|Sep 05, 2024
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.

William O Hahn, K Rachael Parks, Mingchao Shen

|Jun 18, 2024
Adolescent BCG revaccination induces a phenotypic shift in CD4<sup>+</sup> T cell responses to Mycobacterium tuberculosis.

One B Dintwe, Lamar Ballweber Fleming, Valentin Voillet

|Mar 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming.

Allan C deCamp, Martin M Corcoran, William J Fulp

|Jun 09, 2023
Persistent serum protein signatures define an inflammatory subcategory of long COVID.

Aarthi Talla, Suhas V Vasaikar, Gregory Lee Szeto

|May 24, 2023
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.

Kristen W Cohen, Stephen C De Rosa, William J Fulp

Pageof 2

Frequent Collaborators

6 joint publications

Kristen W Cohen

6 joint publications

Aaron Seese

6 joint publications

M Juliana McElrath

4 joint publications

William R Schief